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Abstract
The metabolic syndrome (MetS) greatly increases risk of cardiovascular disease and diabe-
tes and is generally associated with abnormally elevated postprandial triglyceride levels.
We evaluated intestinal synthesis of triglyceride-rich lipoproteins (TRL) in a mouse model of
the MetS obtained by feeding a palm oil-rich high fat diet (HFD). By contrast to control mice,
MetS mice secreted two populations of TRL. If the smaller size population represented 44%
of total particles in the beginning of intestinal lipid absorption in MetS mice, it accounted for
only 17% after 4 h due to the secretion of larger size TRL. The MetS mice displayed accen-
tuated postprandial hypertriglyceridemia up to 3 h due to a defective TRL clearance. These
alterations reflected a delay in lipid induction of genes for key proteins of TRL formation
(MTP, L-FABP) and blood clearance (ApoC2). These abnormalities associated with blunted
lipid sensing by CD36, which is normally required to optimize jejunal formation of large TRL.
In MetS mice CD36 was not downregulated by lipid in contrast to control mice. Treatment of
controls with the proteosomal inhibitor MG132, which prevented CD36 downregulation,
resulted in blunted lipid-induction of MTP, L-FABP and ApoC2 gene expression, as in MetS
mice. Absence of CD36 sensing was due to the hyperinsulinemia in MetS mice. Acute insu-
lin treatment of controls before lipid administration abolished CD36 downregulation, lipid-
induction of TRL genes and reduced postprandial triglycerides (TG), while streptozotocin-
treatment of MetS mice restored lipid-induced CD36 degradation and TG secretion. In vitro,
insulin treatment abolished CD36-mediated up-regulation of MTP in Caco-2 cells. In conclu-
sion, HFD treatment impairs TRL formation in early stage of lipid absorption via insulin-
mediated inhibition of CD36 lipid sensing. This impairment results in production of smaller
TRL that are cleared slowly from the circulation, which might contribute to the reported
association of CD36 variants with MetS risk.
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Introduction
Diet induced obesity is prevalent worldwide together with its co-morbidities. The obesity asso-
ciated metabolic syndrome (MetS), is a cluster of risk factors that include in addition to
abdominal obesity, fasting dyslipidemia (high triglycerides (TG), low serum HDL-cholesterol),
hypertension, and elevated fasting blood glucose. The MetS greatly increases risk of diabetes,
cardiovascular disease and stroke. A positive correlation has been described between risk of
MetS and dietary lipid content [1, 2]. Abnormally elevated postprandial TG levels are generally
reported in individuals with MetS [3–5] suggesting an altered response to dietary fat. Like fast-
ing TG, postprandial TG strongly associates with higher risk of heart disease, stroke, and all-
cause mortality [6–8].
The small intestine determines lipid bioavailability after a meal by secreting the TG-rich
lipoproteins (TRL) or chylomicrons, which are a major component of postprandial lipids. The
small intestine can adapt its lipid absorption capacity to dietary fat content through inducing
intestinal proliferation and expression of the main proteins involved in forming chylomicrons.
These adaptations induce modifications of the quantity and lipid content of the secreted chylo-
microns, which could influence postprandial TG levels and clearance [5–8]. Thus the small
intestine would not only impact the development of obesity but also that of dyslipidemia and
could play an important role in MetS etiology.
To adapt absorption capacity to dietary TG content, enterocytes require the lipid sensor
CD36, which binds long-chain fatty acids (LCFA) and is highly expressed on the apical mem-
brane of enterocytes mainly localized in proximal intestine. CD36 promotes chylomicron for-
mation [9–12] and CD36-mediated signaling during absorption is needed for lipid induction
of two key proteins of chylomicron formation, ApoB48 and Microsomal Triglyceride-Transfer
Protein (MTP) [13]. In addition, CD36 was reported to be part of the prechylomicron trans-
port vesicle and to be important for the vesicle’s budding from the endoplasmic reticulum [14].
These functions of CD36 may explain why its deficiency in humans and rodents associates
with production of a larger proportion of smaller chylomicron particles that persist in the cir-
culation resulting in postprandial hypertriglyceridemia [9, 10, 15]. Genetic studies in humans
have demonstrated a link between CD36 variants and risk of the MetS in several populations
[16–18]. Based on all these findings we examined if MetS induced by high fat diet, associates
with abnormal lipid regulation of intestinal CD36 and if this disrupts the adaptive increase in
expression of key proteins of chylomicron formation. Our data show that this diet induced




Anti-CD36 (R&D System), anti-phospho AKT and anti-AKT (Cell Signaling Technology),
anti-Heat shock protein 70 (HSC70) (Santa Cruz Biotechnology) primary antibodies and the
secondary antibody peroxidase conjugate (Santa Cruz Biotechnology) were obtained from
commercial sources.
Biochemical plasma analyses
TG, cholesterol and Free Fatty Acids (NEFA) levels were determined in plasma using enzy-
matic reaction kits (Biomerieux, Diasys). Insulin was assessed using an ultra-sensitive mouse
insulin ELISA kit (Mercodia).
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Animals and diets
Animal care and procedures were in accordance with the guidelines and regulations of the Insti-
tutional Animal Care and Use Committee of the University of Burgundy (Comité d'Ethique de
l'Expérimentation Animale Grand Campus Dijon, CNEA, Number: 105) which approved this
study. All sacrifice was performed under isofluran anesthesia, and all efforts were made to mini-
mize suffering. Four-week-old wild type C57BL/6J males (80) from Charles River (France) and
12 weeks old male CD36 (+/+) and CD36 (-/-) mice [19] were housed (n = 5 per cage) under
12-h light/dark cycles at 23°C and allowed unrestricted access to laboratory chow (4RF21, Muce-
dola) containing 3% (w/w) lipids (Control diet) and water. For generation, of MetS mouse
model, after 5 days of acclimatization, the wild type mice were fed a high fat diet (HFD) contain-
ing 34.2% (w/w) lipids provided by palm oil for 10 to 14 weeks. Control mice were fed control
diet. Body mass was followed weekly, and food intake was estimated on 24 h. Body composition
was measured using an EchoMRI body composition analyzer (Echo Medical Systems). Only
HFDmice exhibiting percentages of body fat mass and fasting insulinemia 20% higher than
those values in control mice were used in the experiments. Stool lipids were extracted from an ali-
quot of feces (50 mg) collected every 24 h using the Folch method [20].
Insulin tolerance test
Blood was drawn from the tail vein of overnight-fasted control and MetS mice at 0 to 120 min
following an insulin intraperitoneal injection (0.5U/kg insulin (Humalog, Lilly)) and the glu-
cose concentration was determined using a glucose meter (OneTouch Ultra). The area under
the curve (AUC) was calculated for each group of mice.
Lipid load test and TRL size analysis
Control and MetS mice were fasted overnight and were forced-fed 0.5 ml of oil (Isio4 oil,
Lesieur). Blood was drawn from the tail vein before gavage and at different time post-gavage
for plasma TG concentration determination. To evaluate TG secretion in fasting and postpran-
dial conditions and the size of lipoprotein in blood, mice were injected 10 min before the
gavage with tyloxapol (Sigma-Aldrich, 500 mg/kg), an inhibitor of LPL. The size distribution of
lipoproteins was estimated 1 h, 2 h and 4 h after the lipid load using dynamic light scattering
(DLS). DLS measurements were taken at room temperature using a NicompTM 380 (PSS
Nicomp) on plasma dilutions containing 0.2 g/L of TG for 10 min using an automatic channel
width.
Postprandial regulation of genes involved in TRL formation
Control and MetS mice were fasted overnight before oil gavage (0.5 mL Isio4 Lesieur) and sac-
rificed at 0, 1 h and 6 h after the lipid load by isoflurane anesthesia. The small intestine was
divided into three equal parts. The first cm from the mid part of the small intestine considered
as the jejunum was treated for immunohistochemistry. The mucosa from the rest of the jejunal
segments and the distal part (ileum) was scraped for homogenate preparation and for mRNA
analysis.
The same protocol was performed 4 h after the lipid load in CD36 (+/+) and CD36 (-/-)
mice subjected to an intraperitoneal injection of 100 μl DMSO containing or not (control) the
proteasome inhibitor MG132 (14 mg/kg) 30 min before gavage.
The effect of insulin was evaluated in fasted wild type mice after single intraperitoneal injec-
tion of insulin (0.5 U/kg Humalog) 30 min before tyloxapol treatment (500 mg/kg) and 20 min
before the oil bolus (0.5 mL). The animals were sacrificed 2 h after the lipid load.
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The effect of pre-treating MetS mice with a single retro-orbital injection of 100 mg/kg of
streptozotocin (STZ) (Sigma-Aldrich) freshly dissolved in 0.1 M citrate buffer, pH 4.5, was also
evaluated. Six days after STZ or vehicle injection, mice were submitted to the same nutritional
experiments than that described for insulin treatment.
Caco-2 cell lines
The human Caco-2 line (ATCC1HTB37) was cultured in Dulbecco’s modified eagle’s
medium (DMEM, Invitrogen) with 20% fetal bovine serum (FBS), 1% essential amino acids,
50μg/mL gentamicin/streptomycin. Caco-2 cells stably expressing human CD36 (CD36WT)
have been generated as described in [21]. After selection with hygromycin (50 μg/mL), cells
were cultured during 21 days post-confluence before experiments.
Fresh lipid micelles were generated with sodium taurocholate (Sigma-Aldrich, 500 μM) and
linoleic acid (LA) (Sigma-Aldrich, 200 μM) emulsified in NaPO4 buffer (NaH2PO4 (85 mM),
Na2HPO4 (45 mM), pH 6.5) by sonication (20 min, 37°C). 3 h after starvation in medium with-
out FBS, cells were incubated during 1 h in presence of micellar LA. Some Caco-2 cells were
pre-treated with insulin (100 nM, Sigma-Aldrich) 1 h before micellar LA.
Real-time PCR
Total RNA was isolated from mucosa using an RNeasy mini kit (Qiagen), and 0.5 μg of total
RNA was reverse transcribed using a high capacity cDNA reverse transcriptase kit (Applied
Biosystems). Then, this cDNA served as a template for real-time qPCR, which was performed
using an Applied Biosystems StepOnePlusTM thermocycler. The 36B4 / RLP0 gene was used as
a housekeeping gene. Primers and probes for all genes were obtained from Applied Biosystems.
The data were quantified using the 2-ΔΔCt method.
Immunohistochemistry and western blotting
5 μm sections were mounted on charged glass sides, deparaffinized in xylene and processed for
immunohistochemical detection of CD36 [22].
Scraped jejunal mucosa samples were homogenized with buffer A (1 g/16.7 mL of 100 mM
mannitol and 10 mM Tris-HCl, pH 7.1). Protein levels were determined using Western blot-
ting [23].
Statistical analysis
All the data are presented as the mean ± SEM. Statistical significance (p<0.05) was determined
using Student's t-test or a one-way ANOVA, followed by Tukey’s test. The analysis of TRL dis-
tribution was determined using the Kolmogorov test and the mixmodCluster function of R
software (version 3.0.3).
Results
A high fat diet rich in saturated fat recapitulates features of the MetS and
post-prandial hypertriglyceridemia
As expected, mice chronically fed (10 weeks) a diet rich in palm oil (34.2% lipid w/w) became
obese compared with mice fed a control diet containing only 3% lipid (w/w) and developed
fasting hypertriglyceridemia and hypercholesterolemia (Table 1). Despite the 10-fold higher
daily lipid intake, the lipid content in the feces of the HFD fed animals was lower than controls,
confirming efficient adaptation of intestinal net absorption capacity [20]. These mice also dis-
played more pronounced hyperinsulinemia (× 2) associated with a significant increase in
Intestinal CD36 Deregulation and Hyperinsulinemia
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fasting glycemia (Table 1). These modifications were consistent with abnormal systemic insulin
tolerance (Table 1). Based on these metabolic alterations, we propose that the mice fed the HFD
enriched in palm oil provide a rodent model of the MetS and are referred to as MetS mice.
However non fasting state is more representative of current eating behaviors, because 1) it is
the most frequent nutritional state 2) it incorporates the organism’s response to dietary fat
intake and 3) postprandial lipidemia constitutes an independent risk factor for metabolic dis-
ease [6–8]. To examine howMetS and control mice handle dietary fat, they were challenged
with an oral lipid load after an overnight fast. The lipid load triggered a much larger increase of
plasma TG level in MetS mice after 1 to 3 h, as compared with control mice (Fig 1A). Blood lev-
els of NEFA were lower at zero time (fasting) in MetS mice as compared to controls, but the
response to the meal differed. While levels tended to drop at 1 h in controls, they increased in
the MetS group suggesting impaired suppression of plasma NEFA by feeding despite the asso-
ciated increase in insulin and consistent with systemic insulin resistance (Fig 1B) [24].
Production of triglycerides rich lipoproteins (TRL) is altered in MetS mice
Because postprandial TG is largely due to intestinal TG secretion, we measured blood TG
secretion during 4 h after the lipid load using a lipoprotein lipase (LPL) inhibitor, Tyloxapol.
TG secretion was similar to control mice until 3 h, but became significantly higher 4 h after the
lipid load (Fig 1C). This data indicated that postprandial lipemia observed in MetS mice from
1 to 3 h after the lipid load was not due to hyper TG secretion. The TG secretion measured
without a fat challenge is similar in either mice group. This result indicated that the TG secre-
tion coming mainly from liver could not explain the differences of TG secretion observed dur-
ing the postprandial state in either mice group (Fig 1C).
Table 1. Effect of high fat diet on selected body and blood parameters and energy intake in mice.
CONTROL MetS
BODY AND INTESTINAL PARAMETERS
Body mass (g) 25.4 ± 0.5 32.4 ± 0.4 ***
Fat mass (% body weight) 9.6 ± 0.3 26.9 ± 0.5 ***
Lean mass (% body weight) 77.5 ± 0.4 63.4 ± 0.5 ***
Epididymal adipose tissue (% body mass) 0.77 ± 0.05 2.85 ± 0.21***
FASTING BLOOD PARAMETERS
Triglycerides (g/L) 0.58 ± 0.02 0.85 ± 0.04 ***
Cholesterol (g/L) 0.71 ± 0.03 1.28 ± 0.05 ***
Glucose (g/L) 0.83 ± 0.03 1.45 ± 0.10 ***
Insulin (ng/L) 79 ± 2 167 ± 3 *
Insulin Tolerance Test (AUC) 100 ± 4 192 ± 22 ***
ENERGY INTAKE
Caloric intake (kcal / day) 9.7 ± 0.2 13.7 ± 0.2 ***
Lipid intake (mg / day) 92 ± 2 926 ± 13.5 ***
Fecal Lipid content in feces (mg / day) 25.3 ± 2.5 14.2 ± 2.0 ***
C57Bl/6J mice were fed for 10 weeks either a control diet or a high-fat diet rich in palm oil. Body composition was estimated by EchoMri and blood
markers were quantiﬁed after one night of fasting (n = 20/group). Energy intake (n = 20/group) and lipids in feces (n = 7/group) were estimated on 24 h.
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Because the TRL size was also able to modify their clearance, large TRL exhibiting a greater
affinity for LPL than smaller ones [25], we estimated secreted TRL size by DLS analysis 1 h, 2 h
and 4 h after the lipid load. The TRL size distribution from control and MetS mice which was
similar 1 h after the lipid load (Fig 1D), was significantly distinct 2 h after the gavage as shown
in Fig 1E (Kolmogorov test, P<0.001). Indeed, plasma lipoproteins in control mice displayed a
normal distribution around a mean apparent diameter of 156 ± 28 nm. In MetS mice, two lipo-
protein populations were observed, with about 44% of particles having a mean apparent diame-
ter of 103 ± 12 nm and 56% of particles having a diameter of 228 ± 29 nm (Fig 1). 4h after the
lipid load, the TRL size distribution from control and MetS was still significantly different (Kol-
mogorov test, P<0.001). MetS mice still displayed two lipoprotein populations, but with only
about 17% of total particles having a mean apparent diameter of 91 ± 6 nm and 83% of particles
Fig 1. MetSmice display higher postprandial lipemia than controls and altered TRL particle distribution. Plasma TG (A) and NEFA (B) quantified after
an intragastric lipid load (0.5 mL) in control and MetS mice. TG secretion as a function of time after or not the lipid load in mice pre-injected retro-orbitally with
the LPL inhibitor (tyloxapol, 500 mg/kg) (C). Lipoprotein particle distribution in the plasma estimated using DLS in mice injected with tyloxapol at 1h (D), 2 h
(E) and 4 h (F) after the lipid bolus. Means ± SEM, n = 8 (A, B and C), n = 5 (D, E), n = 11 (F), means with same letter are not significantly different, *P < 0.05,
***P < 0.001.
doi:10.1371/journal.pone.0145626.g001
Intestinal CD36 Deregulation and Hyperinsulinemia
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having a diameter of 263 ± 20 nm. The lower proportion of smaller particles which likely corre-
sponded to the remaining of the smaller particles secreted earlier, indicated that MetS mice have
acquired the capacity to secrete large TRL later during the process of lipid absorption. Indeed,
after 4h the TRL secreted by MetS mice were larger than those from control which have a mean
apparent diameter of 190 ± 27 nm and might be more efficiently degraded (Fig 1F).
Dietary lipid-induced regulation of genes involved in intestinal TRL
secretion was altered differently along intestine in MetS mice
To explore whether alterations in the TRL size distribution found in the early postprandial
state of MetS mice could reflect a defect of the lipid-mediated response of the TRL intestinal
metabolism, mRNA levels of key genes involved in their synthesis were assayed at 1 h but also
6 h after oil gavage when hypertriglyceridemia was normalized (Fig 2). Analysis of gene expres-
sion showed that in control mice 1 h after the gavage, mRNA level of ApoB and two genes lim-
iting for TRL synthesis (MTP, L-FABP) involved respectively in the ApoB48 lipidation and the
Fig 2. Coordinate induction of genes involved in chylomicron synthesis and clearance is delayed in MetSmice. After overnight fasting, control and
MetS mice were gavaged with 0.5 mL oil and sacrificed 1 and 6 h later. Jejunal mRNA levels of genes of interest were evaluated by real-time PCR and
normalized to 36B4 mRNA. Induction of gene expression is shown at 1 h (A) and 6 h (B) after the lipid load as compared with fasting in control and MetS
mice. Means ± SEM, n = 5 or 6, *P < 0.05, **P < 0.01, ***P < 0.001. Induction of gene expression obtained from control and MetS mice was also compared
across groups # P < 0.05, ## P < 0.01.
doi:10.1371/journal.pone.0145626.g002
Intestinal CD36 Deregulation and Hyperinsulinemia
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pre-chylomicron transport vesicle formation were increased as compared to the fasted state. In
addition mRNA levels of ApoC2, an activator of LPL, was also increased. Interestingly, this
increase was blunted in MetS (Fig 2A). No change was observed in either mice group in the
expression of ApoC3, an inhibitor of LPL or of NPC1L1, a protein important for cholesterol
absorption [26]. The changes observed in gene expression were normalized at 6 h after the
lipid load except for ApoB and DGAT1 (Fig 2B). The differences in gene expression observed
during the postprandial period in MetS mice and controls were not present in the fasted state
(Table 2). Expression of key proteins of TRL formation such as MTP and L-FABP was similar
in MetS and controls indicating that the differences observed after the lipid gavage were spe-
cific to the postprandial state. However, both DGAT1 and ApoB mRNA levels were higher in
fasted MetS mice indicating that these mRNA were altered by the HFD diet treatment
(Table 2).
The highest TG secretion observed in MetS 4 h after the lipid load (Fig 1C) despite the
absence of induction of the jejunal mRNA level of key genes of TRL formation raised the ques-
tion of a possible compensatory adaptation of the distal intestine to the process of lipid absorp-
tion [27]. To verify this hypothesis we measured gene expression of protein involved in
chylomicron formation and known to be up regulated by fatty acids (L-FABP, MTP) in ileum
[28, 29]. As shown in Fig 3, we observed significant induction of MTP, L-FABP in MetS com-
pared to control mice 6 h after the gavage. Moreover, NPC1L1 known to be down-regulated by
fatty acids [29], was decreased in MetS mice compared to control mice (Fig 3). It is noteworthy
that no different effect between the mice was observed 1 h after the lipid load (S1 Fig).
The postprandial regulation of the lipid sensor CD36 is altered in
proximal intestine of MetS mice
Sustained postprandial hypertriglyceridemia is characteristic of the CD36 deficient mouse [9]
and there is evidence that it might also occur in humans with CD36 deficiency [10]. Moreover,
the CD36 (-/-) mouse is also characterized by secretion of a larger proportion of smaller chylo-
microns that approximate in size the very low density lipoproteins [12]. To finish, in the early
stage of intestinal absorption (proximal part), dietary lipids induce in a CD36-dependent man-
ner the two key genes involved in TRL formation MTP and ApoB48. This event associates with
ubiquitination and degradation of the CD36 protein [13]. Therefore we examined whether
postprandial regulation of CD36 was altered in the main site of both lipid absorption and
CD36 expression i.e jejunum [12] of MetS mice using a combination of immunohistochemistry
Table 2. Metabolic syndrome effect on the jejunal expression of genes involved in chylomicron
synthesis.
GENES CONTROL MetS
CD36 1.00 ± 0.15 0.99 ± 0.07
DGAT1 1.00 ± 0.09 1.52 ± 0.18*
ApoB 1.00 ± 0.14 1.74 ± 0.32*
MTP 1.00 ± 0.05 0.91 ± 0.06
L-FABP 1.00 ± 0.08 1.15 ± 0.11
ApoC2 1.00 ± 0.09 1.24 ± 0.13
ApoC3 1.00 ± 0.22 1.05 ± 0.17
NPC1L1 1.00 ± 0.08 1.09 ± 0.15
Control and MetS mice were sacriﬁced after fasting overnight, and gene expression was analyzed by real-
time PCR. The data were normalized to 36B4 mRNA. Means ± SEM, n = 6, *P < 0.05.
doi:10.1371/journal.pone.0145626.t002
Intestinal CD36 Deregulation and Hyperinsulinemia
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and western blotting at 1 and 6 h after the lipid load (Fig 4). Similar to what we previously
reported in control mice, CD36 was removed from the brush border membrane (BBM) of
enterocytes 1 h after the lipid load (Fig 4A). In contrast, in MetS mice, immunohistochemistry
data showed that the CD36 protein remained at the brush border membrane (BBM) (Fig 4A)
and there was no modification of its level in the intestinal mucosa (Fig 4B). In addition, while
CD36 mRNA level decreased in control mice after the oil gavage it was not affected by the lipid
load in MetS mice (Fig 4C). The defect in postprandial CD36 regulation observed in the proxi-
mal intestine might alter optimization of TRL synthesis.
Down-regulation of CD36 is required in proximal intestine for induction of
genes of chylomicron synthesis
To determine in vivo whether the lack of postprandial regulation of CD36 might be responsible
for the defect in lipid-dependent induction of mRNA levels of TRL formation genes and clear-
ance wild type mice and CD36 (-/-) were treated with the proteasome inhibitor MG132 before
oil gavage. In presence of MG132, the lipid load associated in intestines of control mice with
higher CD36 protein (Fig 5A) and mRNA (Fig 5B) as compared to lipid alone. In addition,
mRNA levels of the key TRL genes, MTP, L-FABP and ApoC2 were lower in presence of
MG132 (Fig 5B) whereas no effect was observed for DGAT1 and ApoB. In contrast to findings
in control mice, MG132 treatment did not alter levels of TRL genes in the intestines of CD36
(-/-) mice given a lipid load.
These data suggest that CD36 degradation induced by dietary lipids is required for the sig-
naling that mediates lipid-induced gene expression of MTP, L-FABP and ApoC2.
Hyperinsulinemia simultaneously alters postprandial regulation of
intestinal CD36 proteins and TRL secretion
Interestingly, in MetS mice postprandial insulin increased greater than two fold above fasting
levels as compared with no effect in control mice. At 1 h post the meal, insulin level in MetS
mice were four fold higher than the levels observed in controls (Fig 6A). Insulin was
Fig 3. Genes involved in chylomicron synthesis are upregulated by fatty acids in ileum of MetSmice.
After an overnight fast, control and MetS mice were gavaged with 0.5 mL oil and sacrificed 6 h later. Ileal
gene expression levels were evaluated by real-time PCR and normalized to 36B4 mRNA. Data presented
show induction of gene expression 6 h after the lipid load as compared with fasting in control and MetS mice.
Means ± SEM, n = 5 or 6, *P < 0.05.
doi:10.1371/journal.pone.0145626.g003
Intestinal CD36 Deregulation and Hyperinsulinemia
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demonstrated to counteract lipid-mediated CD36 ubiquitination and degradation [30], so we
examined if the hyperinsulinemia observed in MetS mice after a lipid load, could be responsible
for the absent response of CD36 to dietary lipid. First, consistent with the ambient postprandial
hyperinsulinemia present in MetS mice 1 h after oil gavage, the intestines of these mice, as
compared with controls, had much higher levels of phosphorylated AKT (Fig 6B), higher
mRNA content of the insulin receptor (IR) and insulin receptor substrate 1 (IRS1) (Fig 6C). In
addition, there was a negative correlation between the level of insulinemia 1 h after the gavage
and that of postprandial CD36 suggesting a role of postprandial hyperinsulinemia in the
impaired lipid response of intestinal CD36 in MetS mice (Fig 6D). To explore this further, we
treated control mice with insulin (0.5 U/kg) just 30 min before the oil gavage. As shown in Fig
7A, insulin treatment significantly reduced the lipid-induced CD36 degradation observed after
oil gavage. Interestingly, as shown with MG132 treatment (Fig 5B), insulin treatment associ-
ated with loss of lipid up-regulation of MTP, L-FABP and ApoC2 mRNA levels whereas insulin
alone had no effect on these parameters (Fig 7B). Consistent with these changes insulin
Fig 4. Abnormal lipid-mediated regulation of CD36 in MetSmice.Overnight fasted (0) control and MetS mice were given a lipid load, sacrificed 1 h and 6
h later and CD36 in the jejunal epithelium was immuno-detected by immunohistochemistry (A) and western blotting (B). Jejunal mRNA level of CD36
evaluated by real-time PCR after normalization to 36B4 mRNA (C). Means ± SEM, n = 6, means with same letter are not significantly different.
doi:10.1371/journal.pone.0145626.g004
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treatment associated with reduced intestinal TG secretion (Fig 7C) and a lower size TRL (Fig
7D). To directly examine the effect of insulin, in the lipid effect mediated by CD36 in the regu-
lation of the mRNA of key proteins of TRL formation, we used Caco-2 cell lines stably trans-
fected with native human CD36 (CD36 WT) [21]. Control cells were stably transfected with
the empty vector (Fig 7E). Differentiated Caco-2 cells with native CD36 displayed 10 fold
higher MTP mRNA level as compared to vector controls (Fig 7E). Cell treatment with micellar
LA for 1 h, increased MTP mRNA levels only when Caco-2 cells were stably transfected with
native CD36 (Fig 7E). Moreover, according to in vivo data, addition of insulin together with
LA suppressed the effect of LA to induce MTP mRNA while insulin alone had no effect.
Interestingly, when the MetS mice were injected with streptozotocin that resulted in a 3-fold
decrease of insulin levels (from 6.1 ± 1.1 μg/L to 1.8 ± 0.1 μg/L), lipid-dependent CD36 degra-
dation (Fig 8A), and postprandial induction of MTP, L-FABP and ApoC2 mRNA levels (Fig
8B) were restored. This also associated with an increase in postprandial TG secretion measured
during the early stage of lipid absorption (Fig 8C).
Discussion
We previously reported that jejunal CD36 senses dietary lipid, which down-regulates its brush
border levels and downstream signaling to stimulate chylomicron synthesis. In this study we
demonstrate for the first time that diet-induced obesity, hypertriglyceridemia and hyperinsuli-
nemia associate with defective down-regulation of CD36 by dietary lipid. This defect leads to a
Fig 5. Lipid-mediated induction of genes involved in chylomicron synthesis is dependent on CD36
proteasomal degradation. Fasted CD36 (+/+) and CD36 (-/-) mice were intraperitoneally injected with
MG132 (14 mg/kg) 30 min before oil gavage and sacrificed 4 h later. (A) CD36 expression standardized to
HSC70 as the loading control. (B) mRNA level analysis by real-time PCR normalized to 36B4 mRNA.
Means ± SEM, n = 5. *P < 0.05.
doi:10.1371/journal.pone.0145626.g005
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delay of lipid-induced stimulation of genes crucial for efficient chylomicron formation (MTP,
L-FABP) and clearance (ApoC2) in the jejunum, the main site of lipid absorption. Thus at
early stages of absorption, the jejunum has a diminished capacity to synthesize large chylomi-
crons, which results in more lipid reaching the ileum where there are probably absorbed.
We provide compelling evidence for the role of the hyperinsulinemia in promoting resis-
tance of CD36 to lipid regulation in the MetS mouse model. Our observations provide insight
in the role of CD36 into the etiology of postprandial dyslipidemia.
Mice, fed a HFD rich in palm oil, which contains about 45% palmitic acid, 40% oleic acid
and 10% linoleic acid, develop features of the MetS. These data are in line with findings that
diets relatively high in saturated fatty acids can induce obesity in mice [31] and humans [32].
In our MetS rodent model, postprandial triglyceridemia is increased, similar to what is gener-
ally reported in humans [3–5]. Our data provide evidence that the postprandial hypertriglyceri-
demia observed in MetS mice up to 3 h after the lipid load is not due to higher intestinal or
hepatic TG secretion but due to a decrease in the clearance efficiency. This defect might be
Fig 6. Small intestinal effects of postprandial hyperinsulinemia in MetSmice. Plasma insulin levels at 0 (fasted) and 1 and 6 h after the lipid load. Means
with same letter are not significantly different (A). AKT activation in the jejunal mucosa from overnight fasted control and MetS mice 1 h after the lipid bolus.
Phosphorylated AKT level was standardized to total AKT (B). mRNA levels of the insulin receptor and insulin receptor substrate 1 in fasted mice measured by
real-time PCR (normalized to 36B4 mRNA). Means ± SEM, n = 5 or 6, * P < 0.05 (C). Correlation between plasma insulin level and percentage drop in jejunal
CD36 protein in control and MetS mice, 1 and 6 h after a lipid load expressed relative to levels in fasted mice. Pearson correlation, n = 22, P<0.05 (D).
doi:10.1371/journal.pone.0145626.g006
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partly explained by the presence of a substantial fraction of smaller intestinal TRL particles
especially produced in early stage of lipid absorption. Smaller chylomicrons are poorly hydro-
lyzed by LPL and also compete for LPL degradation of the larger particles [25, 33, 34]. In addi-
tion, the lack of postprandial up-regulation of intestinal ApoC2, the LPL specific cofactor
(corresponding to 50% less mRNA level, compared to control mice) [35], may further reduce
TRL clearance by LPL in early stage of lipid absorption. Indeed, such a defect may greatly affect
LPL activity because 1) it is known that an addition of ApoC2 to chylomicrons from ApoC2
deficient patients, causes an immediate 100-fold increase in LPL activity [36] and 2) no modifi-
cation of hepatic ApoC2 mRNA level (the other ApoC2 source) was observed during the post-
prandial periods in either group mice (S2 Fig). To finish, the postprandial elevation of NEFA
levels, which also inhibit LPL [34] was higher in MetS mice.
Fig 7. Insulin opposes lipid-downregulation of CD36 and its downstream effects in control mice. Fasted mice were intraperitoneally injected with
insulin (0.5 U/kg) 30 min before tyloxapol (500mg/kg) and oil gavage (0.5 ml oil) and sacrificed 2 h later. Insulin and oil effect on (A) Jejunal CD36 level, (B)
mRNA levels of key chylomicron metabolism genes (normalized to 36B4 mRNA), (C) plasma TG secretion (from tail vein blood) and (D) TRL size estimated
in plasma by DLS. (E) CD36-dependent induction of MTPmRNA levels in Caco-2 cells transfected with an empty vector (vector) or native CD36 (WT CD36).
Cells were grown in medium with 20% FBS until 21 days post-confluence, serum-starved for 3h, pre-treated or not with insulin (1 h, 100 nM) before medium
addition of linoleic acid-micelles (Sodium taurocholate/Linoleic acid 500 μM/200 μM). MTPmRNA evaluated by real-time PCR was normalized to RLPO
mRNA. Means ± SEM, n = 4 or 5, means with same letter are not significantly different. ** P<0.01, ***P<0.001.
doi:10.1371/journal.pone.0145626.g007
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The smaller-size TRL fraction observed in MetS mice likely reflects the delayed induction in
the jejunum, where most fat is normally absorbed, of MTP and L-FABP, important for
ApoB48 lipidation and formation of the pre-chylomicron transport vesicle, respectively [33,
37]. The jejunal defect in handling dietary lipid observed in MetS mice mostly affects early
stages of intestinal lipid absorption (1 h) since induction of MTP, L-FABP and ApoC2 is
observed at later times (6 h), although not that of DGAT1 or ApoB. Interestingly, a delay both
in the postprandial induction of TRL secretion [38] and in the clearance of TG from chylomi-
crons have been reported in obese patients [39]. Alteration in jejunal absorption efficiency due
to absence of induction of the key genes involved in chylomicron synthesis [40] would result in
more lipids reaching the distal intestine. Indeed, L-FABP mRNA level, which has been shown
to be induced in terminal ileum only when fatty acids were infused directly in this distal part
[28], was up-regulated, as well as MTP mRNA level [41], only in ileum of MetS mice.
The presence of lipids in ileum might also play a role in the etiology of the microbiotal
changes generally correlated with obesity (reduced microbiotal diversity and elevated Firmi-
cutes-to-Bacteroidetes ratio) [27]. This ileal recruitment may explain the lowest loss fecal fat
and therefore the obesogenic effect of this HFD. These data highlight the potential contribution
of suboptimal jejunal absorption of dietary lipid to the pathophysiology of obesity. Indeed, the
abnormal adaptation of jejunal gene expression to the dietary lipid content associates with
more important susceptibility to obesity [42].
The abnormalities of jejunal lipid absorption appear to be consequent to the defect in die-
tary lipid sensing by enterocyte CD36, which is mainly abundant in the proximal intestine and
almost undetectable in the ileum [43]. Intestinal CD36 expression and localization in fasted
MetS mice are not altered as previously reported [44, 45], however CD36 response to dietary
lipid is absent. While jejunal CD36 level is rapidly downregulated after the fat gavage in control
mice, it is unaffected in Mets mice. Moreover, MG132 abolishment of CD36 down regulation
by lipid in control mice impairs lipid-mediated up-regulation of MTP, L-FABP and ApoC2 as
is seen in MetS. The intestines of MetS mice, where CD36 is dysfunctional, similar to the intes-
tines of CD36 deficient mice overproduce smaller TRL particles [10, 46]. The ubiquitination of
Fig 8. Streptozotocin treatment restores lipid-downregulation of CD36 and its associated effects in MetS mice. A retro-orbital injection of
streptozotocin (100 mg/kg) was performed in fasted MetS mice. Six days later, fasted MetS mice were treated with tyloxapol (500mg/kg), given a lipid-bolus
and sacrificed 1.5 h later. (A) CD36 expression in jejunal mucosa (B) Streptozotocin effect on mRNA levels of key chylomicron genes by real-time PCR with
data normalized to 36B4 mRNA (C). Plasma TG secretion. Means ± SEM, n = 5, *P<0.05.
doi:10.1371/journal.pone.0145626.g008
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CD36, which is responsible for its degradation, is also required for its downstream signaling. A
mutated CD36 protein with substitution of the carboxyl terminal lysines that get ubiquitinated
with fatty acid treatment, fails to induce intracellular signaling [47]. Together, these data sug-
gest that HFD treatment results in a defect in posttranslational regulation of CD36, which asso-
ciates with impairment of its dietary lipid sensing function.
In addition to enterocytes, CD36 is also expressed on endocrine cells in the proximal intes-
tine and regulates secretion of the intestinal hormones CCK and secretin, involved in fat diges-
tion and homeostasis [21]. A dysfunction of CD36 may reduce secretions of these hormones
resulting in a reduction of fat digestion capacity, which may further contribute to the overflow
of dietary lipids reaching the distal intestine. Thus abnormal intestinal CD36 function in early
stages of lipid absorption delays the increase in capacity of jejunal lipid absorption and impacts
postprandial hypertriglyceridemia without affecting net lipid intestinal absorption. These data
are consistent with those obtained with CD36 null mice where a crucial role of intestinal CD36
in lipid secretion into the lymph was observed without a change of net intestinal lipid absorp-
tion [9] But it is noteworthy that, a CD36-independent regulatory mechanism, may play a role
later during lipid absorption. This mechanism which may require more time to function would
normalize the increase intracellular levels of ApoC2, L-FABP and MTP and consequently
would increase intestinal TG secretion via an increase of the TRL size. All together these regu-
lations may normalize postprandial triglyceridemia in MetS mice observed after 4 h.
Our data provide several lines of evidence to support the interpretation that hyperinsuline-
mia and especially postprandial hyperinsulinemia counteracts lipid-induced CD36 down-regu-
lation resulting in its dysfunctional response to dietary fat. First, the lipid load triggers
postprandial hyper-insulinemia only in MetS mice. Second, in control mice, acute treatment
with insulin prior to the fat gavage abolishes CD36 protein down-regulation and up-regulation
of MTP, L-FABP and ApoC2 mRNA levels, identical to what is observed with MG132 treat-
ment (Fig 7A and 7B). Third, inhibition of insulin secretion in MetS mice restores CD36 degra-
dation (Fig 8B) and induction of MTP, L-FABP and ApoC2. Finally in Caco-2 cells in vitro,
insulin opposes CD36 dependent-induction of MTP mRNA by LCFA. These findings are con-
sistent with the prior observation of decreased entry of CD36 into degradation pathways in
macrophages from ob/ob mice, a model of obesity, insulin resistance and hyperinsulinemia
[48] and with the in vitro observation that insulin prevents FA-dependent ubiquitination and
degradation of CD36 [30]. Our data suggest that inhibition of intestinal TRL secretion by insu-
lin [49] could be due at least in part to its inhibition of CD36 function.
In conclusion, the postprandial hyperinsulinemia observed in MetS mice alters post-transla-
tional regulation of jejunal CD36, which, in turn, interferes with the adaptive increases in gene
expression important for optimization of TRL synthesis in the proximal intestine. Similar abnor-
malities in the adaptive intestinal response to dietary lipids are associated with obesity in mice
[42] and humans [50]. The defect in jejunal fat absorption consequent to CD36 dysfunction is
also similar to that associated with CD36 deficiency and in both cases is characterized by over-
production of smaller TRL particles that are poorly hydrolyzed by LPL. In addition the jejunal
absorption defect would result in more lipid being absorbed in the ileum [9], an effect that could
impact satiety and energy regulation [51]. Our data might help explain the reported association
of CD36 polymorphisms in the etiology of MetS [52] and they suggest that interventions that tar-
get CD36 and the early stages of fat absorption might have therapeutic advantage.
Supporting Information
S1 Fig. Expression of genes involved in chylomicron synthesis 1h after a lipid load in ileum.
After an overnight fast, control and MetS mice were gavaged with 0.5 mL oil and sacrificed 1 h
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later. Ileal gene expression levels were evaluated by real-time PCR and normalized to 36B4
mRNA. Data presented show induction of gene expression 1 h after the lipid load as compared
with fasting in control and MetS mice. Means ± SEM, n = 5 or 6, P< 0.05. http://dx.doi.org/
10.6084/m9.figshare.1595941
(PDF)
S2 Fig. Hepatic ApoC2 (A) and ApoC3 (B) mRNA level in control and MetS mice. 36B4 was
used as housekeeping gene for QPCR analysis. n = 6 / group, one-way Anova followed to Dun-
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